Representatives from the Point Clear Polo Classic recently made a $93,500 donation to the University of South Alabama to support the USA Cancer Research Institute.
The donation was made possible by proceeds from the 2004 Point Clear Polo Classic. USA's Cancer Research Institute was the primary beneficiary of the charity event, which was held in October.
Polo Classic event leaders Camille Corte, Anne Nix, Bob Edmundson, and Hutch Radcliff presented the check to USA President Gordon Moulton.
"We want to thank the University of South Alabama for bringing the Cancer Research Institute to Mobile," said Radcliff. "We think it's a tremendous asset not only to the city, but also to the region as a whole."
This is the charitable group’s latest installment in what has been a long history of giving to the University. Point Clear Polo has sponsored USA cancer research for more than a decade, generating approximately $2.5 million in support of an endowed chair in cancer research and other projects, including $200,000 in contributions to Project Hope, a program benefiting pediatric cancer patients at USA Children’s and Women’s Hospital. This most recent donation brings the organization’s total contribution to approximately $3 million.
Moulton said support from groups such as Point Clear Polo is critical to the success of the USA Cancer Research Institute.
“The University has been a recipient of Point Clear Polo’s generosity for many years,” Moulton said. “Continued support from organizations such as this one will be very important for the long-term development of this type of cancer center. The money is very important, but the belief in this project by community leaders from organizations like Point Clear Polo is even more important.”
Cancer death rates along the Gulf Coast are some of the highest in the nation. Mobile loses 1,200 people per year to cancer, while annual Baldwin County cancer deaths are about 400.
The USA Cancer Research Institute was created to help prevent, treat and cure cancer in the upper Gulf Coast region. It will increase care and treatment options for cancer patients, providing local access to high technology medicine.